Relmada Therapeutics, Inc. · DUS:4E2

Relmada Therapeutics, Inc. insider trades

Relmada Therapeutics, Inc.'s insiders made 4 buys and 0 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

TradeTradeSharesPriceValueDate
Traversa Sergio
Director, Officer: Chief Executive Officer
Buy100,000USD 4.10US$410KSep 10, 2026
Shenouda Maged
Officer: Chief Financial Officer
Buy79,800USD 4.25US$339KSep 10, 2026
Traversa Sergio
Director, Officer: Chief Executive Officer
Buy100,000USD 4.18US$418KSep 9, 2026
Shenouda Maged
Officer: Chief Financial Officer
Buy120,200USD 4.20US$505KSep 9, 2026

Relmada Therapeutics, Inc. shareholders